Contact us We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits
Wegovy, which has the active ingredient semaglutide, is a brand-name injectable medication approved by the Food and Drug Administration (FDA) in 2021
This analysis uses 2023 Medicare claims for traditional Medicare, Medicare Advantage encounter data, and Part D prescription drug event data to estimate the total number of Medicare beneficiaries with obesity or overweight, the number of Part D enrollees who met the Bridge eligibility criteria in 2023, and those who met the Bridge clinical criteria but who also had diagnoses recorded in claims or encounter data that would qualify for Part D coverage of GLP-1s (type 2 diabetes, OSA, or MASH) or who had a GLP-1 Part D-covered prescription during the year, either of which would make them ineligible for Bridge (see Methods)
and Residency at University of Maryland Board Certified Author of 5 books on weight loss 13 awards for excellent health care Learn More Physician in Towson 15+ years of experience in medical weight loss M.D., University of Pennsylvania Medical Residency, Harvard University Board of Internal Medicine Certification Learn More Eli Luft Chief Operating Officer 8+ years experience in medical weight loss M.S
But are not seeking any brain benefits
In a 12 month study, people going on a plant-based diet had lost an average of 12.1 kg
.webp)
